Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Vergmann AS"'
Publikováno v:
International Journal of Retina and Vitreous, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Background To systematically review the real-world outcomes of intravitreal faricimab treatment in patients with neovascular age-related macular degeneration (nAMD) to evaluate its efficacy and safety in clinical settings. This study was con
Externí odkaz:
https://doaj.org/article/ed620556cd564250adf9e91d90a8e471
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 4, Pp 903-915 (2024)
Abstract Many important abnormalities of the vitreous, retina and choroid are predominantly located in the peripheral retina. In some retinal diseases with both central and peripheral manifestations, pathological structural or vascular changes can be
Externí odkaz:
https://doaj.org/article/327933e26b074e7b9235d4b8834108de
Publikováno v:
International Journal of Retina and Vitreous, Vol 10, Iss 1, Pp 1-12 (2024)
Abstract Diabetes is a prevalent global concern, with an estimated 12% of the global adult population affected by 2045. Diabetic retinopathy (DR), a sight-threatening complication, has spurred diverse screening approaches worldwide due to advances in
Externí odkaz:
https://doaj.org/article/afc5bcc817694d37a8af29ea037255ce
Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 1, Pp 51-69 (2023)
Abstract The port delivery system (PDS) of anti-VEGF therapy provides continuous delivery of ranibizumab (RBZ). In October of 2021, the American Food and Drug Administration (FDA) approved the PDS with RBZ as a treatment option for neovascular age-re
Externí odkaz:
https://doaj.org/article/2eff4b95b46342e9b86320c6a8d99599
Clinical Utilisation of Wide-Field Optical Coherence Tomography and Angiography: A Narrative Review.
Autor:
Nissen, Anne Helene K.1 (AUTHOR), Vergmann, Anna Stage1,2 (AUTHOR) anna.stage.vergmann@rsyd.dk
Publikováno v:
Ophthalmology & Therapy. Apr2024, Vol. 13 Issue 4, p903-915. 13p.
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 5, Pp 2253-2264 (2023)
Abstract Introduction This review aims to assess the efficacy, durability and safety of faricimab—a dual vascular endothelial growth factor and angiopoietin 2 inhibitor—in patients with neovascular age-related macular degeneration (nAMD) and diab
Externí odkaz:
https://doaj.org/article/e2b8a4168e174412896b6966dfb04925
Autor:
Katrine Hartmund Frederiksen, Frederik Nørregaard Pedersen, Anna Stage Vergmann, Dawei Yang, Caroline Schmidt Laugesen, Jesper Pindbo Vestergaard, Torben Lykke Sørensen, Carol Y Cheung, Ryo Kawasaki, Tunde Peto, Jakob Grauslund
Publikováno v:
International Journal of Retina and Vitreous, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Vascular endothelial growth factor inhibitors have substantially improved the visual outcomes in patients with macular edema (ME) caused by branch retinal vein occlusion (BRVO), but treatment outcomes are highly variable and early prediction
Externí odkaz:
https://doaj.org/article/2613afe97bd44a4b9e9dec8340d44262
Autor:
Anna Stage Vergmann, Lonny Stokholm, Katrine Hass Rubin, Anne Thykjær, Sören Möller, Caroline Schmidt Laugesen, Steffen Heegaard, Kurt Højlund, Ryo Kawasaki, Katja Christina Schielke, Jakob Grauslund
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Migraine is a disease characterized by cerebral vasodilation. While diabetes has previously been associated with a lower risk of migraine, it is not known if diabetic retinopathy (DR), a retinal peripheral vascular occlusive disease, is a po
Externí odkaz:
https://doaj.org/article/65833514e5df4a42afcce65d40173e4a
Autor:
Nasimi, Safiullah, Nasimi, Nasratullah, Grauslund, Jakob, Vergmann, Anna Stage, Subhi, Yousif
Publikováno v:
Journal of Personalized Medicine; Sep2024, Vol. 14 Issue 9, p913, 11p
Autor:
Vergmann, Anna Stage, Olsen, Frederik Emil, Nielsen, Anders Bo, Vestergaard, Anders Højslet, Thomsen, Ann Sofia Skou, Konge, Lars, Grauslund, Jakob
Publikováno v:
Acta Ophthalmologica (1755375X); Sep2024, Vol. 102 Issue 6, p697-702, 6p